Uveitis treatment trials-A cross-study perspective

Emmett T. Cunningham*, Debra A. Goldstein, Manfred Zierhut

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

6 Scopus citations
Original languageEnglish (US)
Pages (from-to)63-67
Number of pages5
JournalOcular Immunology and Inflammation
Volume20
Issue number2
DOIs
StatePublished - Apr 2012

Funding

Supported in part by The Pacific Vision Foundation (ETC), The San Francisco Retina Foundation (ETC), and an unrestricted grant from Research to Prevent Blindness, New York, NY, USA (DAG). We thank Nisha R. Acharya, John H. Kempen, and James T. Rosenbaum for thoughtfully reading and commenting on an early version of this editorial. Three and six month response rates and three, six, nine, and twelve month confidence intervals for the MUST Trial arms provided by Elizabeth Sugar, PhD on behalf of the Must Trial Research Group.

ASJC Scopus subject areas

  • Ophthalmology
  • Immunology and Allergy

Cite this